Skip to content

Clinical trial evaluating the safety and effectiveness of bone tissue adhesive in the repair of jaw defects and the enhancement and fixation of implant placement

Research on the use of bone tissue adhesive in the repair of jawbone defects and the enhancement and fixation of implant denture placement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125928
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jawbone defects require repair and dental implant placement to enhance retention

Interventions

Control group:Receiving the bone tissue adhesive from Suzhou Jiuxin Medical Technology Co., Ltd. for guiding jawbone regeneration and repair during simultaneous implant placement and fixation. After
Trial group:Receiving the bone tissue adhesive from Suzhou Jiuxin Medical Technology Co., Ltd. for guiding jawbone regeneration and repair during simultaneous implant placement and fixation. After imp

Sponsors

PLA Air Force Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with insufficient bone mass who require immediate implant restoration; 2. There should be at least 2mm of apical bone below the bottom of the extraction socket; 3. Aged 18-70, male or female who is not pregnant or in lactation; 4. Volunteer to participate in the trial and sign the informed consent form; 5. No obvious inflammation, infection, or lesions in oral soft tissue; 6. Be able to cooperate with this research protocol and accept regular postoperative visits.

Exclusion criteria

Exclusion criteria: 1. Those who plan to have children in the next 2 years; 2. Patients with poor overall health and nutritional status; 3. Individuals with uncontrolled endocrine and metabolic diseases, hematological diseases, and cardiovascular diseases; 4. Suffering from systemic or localized bone diseases such as osteomalacia, osteosclerosis, bone tuberculosis, osteitis, bone tumors, etc; 5. Individuals with systemic immune diseases; 6. Those who have been taking special medications such as hormones and anticoagulants for a long time; 7. Pregnant and lactating women; 8. Patients with mental illnesses, psychological disorders, and neurological diseases such as epilepsy; 9. Patients with jawbone and mucosal lesions; 10. After radiotherapy for the head and neck; 11. Patients with Sjögren's syndrome; 12. Individuals with uncontrolled periodontal disease or poor oral hygiene; 13. Individuals with poor biting habits, such as bruxism at night; 14. Other situations that the researcher deems unsuitable for participation in the trial.

Design outcomes

Primary

MeasureTime frame
Implant stability coefficient (ISQ);Bone resorption volume;Physiological changes;Satisfaction with the repaired effect;Evaluation of the operational performance of equipment;Incidence of adverse events;Incidence of device defects;Health status of soft tissues around implants;

Countries

China

Contacts

Public ContactDeng Tianzheng

PLA Air Force Medical Center

dengtzh@163.com+86 150 0130 6878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026